DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2226283/drug-biotech-stock-q4-earnings-due-on-feb-15-alny-bpmc-more?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2226283 Feb 14, 2024 - Let's look at five biotech/drug companies, ALNY, BPMC, AGIO, CORT and RARE, slated to release quarterly results on Feb 15. 0

https://seekingalpha.com/article/4670850-corcept-therapeutics-incorporated-cort-q4-2023-earnings-call-transcript?source=feed_sector_transcripts Feb 15, 2024 - Corcept Therapeutics Incorporated (NASDAQ:NASDAQ:CORT) Q4 2023 Earnings Conference Call February 15, 2024 5:00 PM ETCompany ParticipantsAtabak Mokari -... 0

https://www.zacks.com/stock/news/2245567/will-corcept-cort-bank-on-korlym-in-2024-amid-stiff-rivalry?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245567 Mar 25, 2024 - Corcept (CORT) expects its sole marketed drug, Korlym, approved for treating Cushing's syndrome, to generate incremental sales and combat stiff competition. 0

https://www.zacks.com/stock/news/2260461/corcept-cort-posts-positive-data-from-cushing-s-syndrome-study?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2260461 Apr 23, 2024 - Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome. 0

https://www.zacks.com/stock/news/2227548/corcept-cort-q4-earnings-beat-estimates-korlym-sales-grow?cid=CS-ZC-FT-analyst_blog|earnings_article-2227548 Feb 16, 2024 - Corcept (CORT) beats on both earnings and sales in the fourth quarter. The company also reiterates its previously provided guidance for 2024. 0

https://www.zacks.com/stock/news/2246798/why-is-theravance-bio-tbph-down-9-since-last-earnings-report?cid=CS-ZC-FT-realtime_blog-2246798 Mar 27, 2024 - Theravance Bio (TBPH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. 0

https://seekingalpha.com/article/4688346-corcept-therapeutics-incorporated-cort-q1-2024-earnings-call-transcript?source=feed_sector_transcripts May 01, 2024 - Corcept Therapeutics Incorporated (NASDAQ:NASDAQ:CORT) Q1 2024 Earnings Conference Call May 1, 2024 5:00 PM ETCompany ParticipantsAtabak Mokari - Chief... 0